Figure 6
From: Upregulation of interleukin-19 in saliva of patients with COVID-19
Plasma interleukin (IL)-19 levels in COVID-19 patients on different treatment regimens. Level of IL-19 in the plasma of COVID-19 patients untreated or treated with corticosteroids, tocilizumab, or IFNβ during their course of hospital treatment. The data show a significant reduced IL-19 plasma level of IFNβ treated patient and a trend of reduction for glucocorticoids or tocilizumab treated COVID-19 patients. Statistical tests: Unpaired t-test or Mann–Whitney U test, depending on the skewness of data. NS nonsignificant. ***P < 0.001.
